Abstract
Stable Fos expression in the osteoblast lineage results in the development of steosarcomas (OS) in mice, yet the underlying mechanisms are poorly understood. Using a genetic system in which Fos expression can be induced in osteoblasts in a doxycycline-dependent manner and through subsequent RNA sequencing and gene set enrichment analysis, we were able to identify novel transcriptional targets of Fos in osteoblasts. These included a distinct activation of cellular response toward replication stress (RS), exemplified by a Fos-dependent induction of the RS-suppressing Chk1 kinase. Importantly, Fos expression protects osteoblasts from RS and DNA damage likely through upregulation of Chk1 and facilitates transformation by Ras/E1A oncogenes. These data reveal a novel function of Fos in safeguarding genome stability during replication, which is particularly relevant in conditions of oncogene-induced S-phase entry.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Cell Cycle |
Vol/bind | 13 |
Udgave nummer | 12 |
Sider (fra-til) | 1980-6 |
Antal sider | 7 |
ISSN | 1538-4101 |
DOI | |
Status | Udgivet - 15 jun. 2014 |
Udgivet eksternt | Ja |